loader image
Tuesday, November 11, 2025
66.4 F
McAllen
- Advertisement -

Therapy Lessens COVID-19 Post-Viral Fatigue 

Translate to Spanish or other 102 languages!

According to a recent study conducted by researchers at Amsterdam UMC, cognitive behavioral therapy is beneficial for individuals with post-viral fatigue following COVID-19. Image for illustration purposes
According to a recent study conducted by researchers at Amsterdam UMC, cognitive behavioral therapy is beneficial for individuals with post-viral fatigue following COVID-19. Image for illustration purposes

Mega Doctor News

- Advertisement -

By Amsterdam UMC

Newswise — According to a recent study conducted by researchers at Amsterdam UMC, cognitive behavioral therapy is beneficial for individuals with post-viral fatigue following COVID-19. The study showed that individuals who underwent behavioral therapy experienced reduced fatigue and concentration problems, as well as improved physical and social functioning. The lead researcher, Professor Hans Knoop, also noted that these improvements were still present six months after treatment. The study has been published in the journal Clinical Infectious Diseases and involved collaboration between Amsterdam UMC, RadboudUMC, and three other hospitals.

After recovering from COVID-19, many patients continue to experience symptoms, commonly known as long-COVID or Post-COVID Syndrome, with severe fatigue being the most common symptom. The ReCOVer study, which was funded by ZonMw, compared patients who received cognitive behavioural therapy with those who received normal care such as supervision by their GP or specialist, physiotherapy, and/or occupational therapy.

- Advertisement -

Tackling fatigue

Cognitive behavioural therapy for patients with post-COVID-19 fatigue aims to help patients manage their symptoms more effectively. This can involve working with patients to improve their sleep patterns and gradually increase their physical activity levels with small, safe steps. According to Professor Hans Knoop, who led the ReCOVer study, the therapy helps patients to become more active and reduce their fatigue levels.

Improving concentration

The study found that cognitive behavioral therapy was effective in reducing fatigue and improving concentration for patients with persistent fatigue after COVID-19. The therapy also helped patients make progress socially and physically. These improvements were still present after six months. The researchers also noted that the therapy was safe and did not result in any worsening of symptoms or new symptoms.

More research required

The researchers want to emphasize that just because behavioral therapy helps alleviate symptoms doesn’t mean that the underlying cause is psychological. They also note that not all patients will benefit from this form of therapy.

It is therefore very important to continue to search for other effective treatments and the physical causes of the post-COVID syndrome.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Study Reveals Strong Link Between Type 2 Diabetes and Hearing Loss

As the United States observes American Diabetes Month this November, a comprehensive study published in Otolaryngology–Head and Neck Surgery, the peer-reviewed journal of the American Academy of Otolaryngology–Head and Neck Surgery Foundation, reveals that individuals with type 2 diabetes face a significantly elevated risk of hearing loss—a complication that often goes unrecognized and unscreened.

Importance of Regular Exercise Outside of Sports

Mega Doctor News CLEVELAND CLINIC - If you enjoy golfing, playing tennis or...

A Specific Human Gene Can Help the Heart Repair Itself from Heart Attack or Heart Failure

A naturally occurring gene called Cyclin A2 (CCNA2), which turns off after birth in humans, can actually make new, functioning heart cells and help the heart repair itself from injury including a heart attack or heart failure when the gene is turned back on.

Global Reviews Call for Urgent Action on Endometriosis in Most World Regions

Endometriosis is estimated to affect one in 10 reproductive-aged women worldwide – but research reveals stark global inequities in how the chronic condition is recognized, treated and prioritized in national health systems.
- Advertisement -
×